Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Himisha Beltran
Headshot: 
Dr. Himisha Beltran, M.D.

Himisha Beltran, M.D.

Hematology Oncology (Advanced Disease)
Headshot: 
Dr. Himisha Beltran, M.D.
Insurance Providers

Insurance Providers

  • AETNA [Medicare]
  • AETNA-HMO
  • AETNA-PPO
  • Aetna-Weill Cornell POS
  • CIGNA
  • EBCBS HMO
  • EBCBS Mediblue
  • EBCBS PPO/EPO
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Oxford Freedom
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Medicare]
  • Rockefeller University-CoreSource
  • United Empire Plan
  • United Health Care
  • United Health Care [Community Plan]

Biography

Body: 

Dr. Himisha Beltran is a medical oncologist who specializes in caring for patients with genitourinary malignancies (prostate cancer, bladder cancer, germ cell tumor, kidney cancer). She joined the Division of Hematology and Medical Oncology as Assistant Professor of Medicine and Urology in 2011.

Dr. Beltran received her undergraduate degree from the University of Oregon, her medical degree from New York Medical College and completed her residency at Hospital of the University of Pennsylvania and her fellowship in Hematology and Medical Oncology at The New York Hospital-Weill Cornell Medical College.  Dr. Beltran is the recipient of numerous awards, including a Prostate Cancer Foundation Young Investigator Award and an AACR Women in Cancer Research Scholar Award.

Dr. Beltran is actively involved in both laboratory-based and clinical research at Weill Cornell Medical College, and she serves as the liaison for several bench-to-bedside translational research efforts.  Dr. Beltran is also directly involved in the development of a research program to study the molecular genetics of advanced prostate cancer, including an aggressive subtype called neuroendocrine (or anaplastic) prostate cancer. By studying the RNA and DNA of these tumors, she is learning how these cancers evolve, identifying molecular alterations to target with drugs, and developing clinical trials to bring new effective therapy to patients.  Her goal is to help develop a cancer research program centered around personalized cancer care, which entails tailoring therapy for patients based on their cancer’s specific molecular profile. She is also involved in writing and leading several genitourinary clinical trials at Weill Cornell, and participates in national and international trials through the Alliance for Clinical Trials in Oncology Foundation (formerly CALGB) and National Cancer Institute (NCI).



© 2016 Weill Cornell Medicine All rights reserved.